Hjem › Atopisk dermatitt (eksem) › New York › New York City
Kliniske studier for Atopisk dermatitt (eksem) i New York City, NY
13 studier for Atopisk dermatitt (eksem) søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
- OptiSkin Medical, New York
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
RekruttererFase 2
- Enveda Investigative Site, New York
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
RekruttererFase 2
- Investigational Site, New York
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Rekrutterer
- Weill Cornell Medicine, New York
- Columbia University Irving Medical Center, New York
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RekruttererFase 2
- Sadick Research Group, LLC, New York
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RekruttererFase 2
- Inmagene Site 21, New York
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
RekruttererFase 3
- Equity Medical /ID# 265814, New York
- Weill Cornell Medicine /ID# 265793, New York
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
RekruttererFase 1
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
RekruttererFase 2
- Private Practice - Dr. Bobby Buka, New York
- Icahn School of Medicine at Mount Sinai, New York
- Sadick Research Group, New York
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
RekruttererObservasjonsstudie
- Galderma Investigational Site - 7051, New York
- Galderma Investigational Site 7109, New York
- Galderma Investigational Site 8279, New York
Allergy and Immunology Natural History Study
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
RekruttererFase 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Pfizer, New York
Atopisk dermatitt (eksem)-studier i andre byer
- Los Angeles, CA11 studier
- Washington, DC11 studier
- San Antonio, TX10 studier
- San Diego, CA10 studier
- Birmingham, AL9 studier
- Miami, FL9 studier
- Dallas, TX8 studier
- Huntington Beach, CA8 studier
- Sacramento, CA8 studier
- Troy, MI8 studier
- Indianapolis, IN7 studier
- Pittsburgh, PA7 studier
Andre studier i New York City
- Brystkreft136 studier
- Ikke-småcellet lungekreft121 studier
- Kreft (alle typer)109 studier
- Prostatakreft103 studier
- Metastatisk kreft93 studier
- Kolorektal kreft78 studier
- Eggstokkreft69 studier
- Lungekreft60 studier
- Multipelt myelom60 studier
- Pankreaskreft60 studier
- Endometriekreft52 studier
- Akut myelogen leukemi51 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.